LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Gyroscope Therapeutics

Similar companies to Gyroscope Therapeutics

Gyroscope Therapeutics Tech Stack

Gyroscope Therapeutics uses 8 technology products and services including SweetAlert2, Swiper, Underscore.js, and more. Explore Gyroscope Therapeutics's tech stack below.

  • SweetAlert2
    Javascript Libraries
  • Swiper
    Javascript Libraries
  • Underscore.js
    Javascript Libraries
  • Open Graph
    Miscellaneous
  • Yoast SEO
    Search Engines
  • HSTS
    Security
  • MediaElement.js
    Video Players
  • YouTube
    Video Players

Media & News

Gyroscope Therapeutics's Email Address Formats

Gyroscope Therapeutics uses at least 1 format(s):
Gyroscope Therapeutics Email FormatsExamplePercentage
F.Last@gyroscopetx.comJ.Doe@gyroscopetx.com
45%
First.Last@gyroscopetx.comJohn.Doe@gyroscopetx.com
8%
FLast@gyroscopetx.comJDoe@gyroscopetx.com
2%
F.Last@gyroscopetx.comJ.Doe@gyroscopetx.com
45%

Frequently Asked Questions

Where is Gyroscope Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Gyroscope Therapeutics's main headquarters is located at 11-21 Northdown Street Northdown House London, England N19BN GB. The company has employees across 4 continents, including EuropeNorth AmericaSouth America.

What is Gyroscope Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Gyroscope Therapeutics is a publicly traded company; the company's stock symbol is VISN.

What is Gyroscope Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Gyroscope Therapeutics's official website is gyroscopetx.com and has social profiles on LinkedIn.

What is Gyroscope Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Gyroscope Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Gyroscope Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2023, Gyroscope Therapeutics has approximately 52 employees across 4 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Financial Officer: J. S.Head Of Talent Acquisition: G. D.External Alliance Lead/ Executive Assistant To Cmo: V. A.. Explore Gyroscope Therapeutics's employee directory with LeadIQ.

What industry does Gyroscope Therapeutics belong to?

Minus sign iconPlus sign icon
Gyroscope Therapeutics operates in the Biotechnology Research industry.

What technology does Gyroscope Therapeutics use?

Minus sign iconPlus sign icon
Gyroscope Therapeutics's tech stack includes SweetAlert2SwiperUnderscore.jsOpen GraphYoast SEOHSTSMediaElement.jsYouTube.

What is Gyroscope Therapeutics's email format?

Minus sign iconPlus sign icon
Gyroscope Therapeutics's email format typically follows the pattern of . Find more Gyroscope Therapeutics email formats with LeadIQ.

How much funding has Gyroscope Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2023, Gyroscope Therapeutics has raised $60M in funding. The last funding round occurred on Nov 08, 2021 for $60M.

When was Gyroscope Therapeutics founded?

Minus sign iconPlus sign icon
Gyroscope Therapeutics was founded in 2016.
Gyroscope Therapeutics

Gyroscope Therapeutics

Biotechnology ResearchEngland, United Kingdom51-200 Employees

About Gyroscope Therapeutics, a Novartis company:

Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022.

Gyroscope’s lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. Food and Drug Administration for the treatment of people with GA.

Guided by a mission to preserve sight and fight the devastating impact of blindness, Gyroscope has built a global organisation combining discovery, research, drug development, a manufacturing platform and surgical delivery capabilities.

Section iconCompany Overview

Headquarters
11-21 Northdown Street Northdown House London, England N19BN GB
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
VISN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2016
Employees
51-200

Section iconFunding & Financials

  • $60M

    Gyroscope Therapeutics has raised a total of $60M of funding over 4 rounds. Their latest funding round was raised on Nov 08, 2021 in the amount of $60M.

Section iconFunding & Financials

  • $60M

    Gyroscope Therapeutics has raised a total of $60M of funding over 4 rounds. Their latest funding round was raised on Nov 08, 2021 in the amount of $60M.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.